Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials

David P Breen; Roger A Barker

doi:10.1016/j.parkreldis.2016.05.012

Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials

David P Breen, Roger A Barker

MultiPark: Multidisciplinary research on neurodegenerative diseases

University of Cambridge

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	121-2
Number of pages	2
Journal	Parkinsonism and Related Disorders
Volume	29
DOIs	https://doi.org/10.1016/j.parkreldis.2016.05.012
Publication status	Published - 2016 Aug

Free keywords

Letter

Access to Document

10.1016/j.parkreldis.2016.05.012

Cite this

@article{a004a1f8039f4f05b7610ceef277583a,

title = "Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials",

keywords = "Letter",

author = "Breen, \{David P\} and Barker, \{Roger A\}",

year = "2016",

month = aug,

doi = "10.1016/j.parkreldis.2016.05.012",

language = "English",

volume = "29",

pages = "121--2",

journal = "Parkinsonism and Related Disorders",

issn = "1873-5126",

publisher = "Elsevier",

}

TY - JOUR

T1 - Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials

AU - Breen, David P

AU - Barker, Roger A

PY - 2016/8

Y1 - 2016/8

KW - Letter

UR - https://www.scopus.com/pages/publications/84969567577

U2 - 10.1016/j.parkreldis.2016.05.012

DO - 10.1016/j.parkreldis.2016.05.012

M3 - Letter

C2 - 27215394

SN - 1873-5126

VL - 29

SP - 121

EP - 122

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

ER -

Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials

Free keywords

Access to Document

Other files and links

Cite this